Nature Reviews Endocrinology

Article	Citations
Exercise-induced plasma factors confer brain benefits	771
Exposing skin to ultraviolet irradiation increases food intake in male individuals	656
Author Correction: Adrenocortical stem cells in health and disease	625
Immune cell population prevents weight regain	602
Dexamethasone in patients with diabetes mellitus	450
Memory of obesity stored in adipocytes	417
Identification of genetic factors of type 2 diabetes mellitus risk in South Asian populations	390
Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead	376
The challenges of assessing adiposity in a clinical setting	268
Non-nutritive sweeteners — too sweet to be wholesome?	261
Timed high-fat diet feeding restores small bowel circadian rhythms	228
Effects of diet on atherosclerotic plaque development	205
Limiting the use and misuse of liothyronine in hypothyroidism	193
The role of DNA damage in diabetic complications	177
Thyroid function and iodine intake: global recommendations and relevant dietary trends	176
CNOT6L regulates hepatokine expression	172
The gut microbiota in obesity and weight management: microbes as friends or foe?	169
Ketosis improves muscle stem cell resilience	165
Metabolite levels during the menstrual cycle	163
Research in metabolic ageing — a tale of mice versus humans?	154
Patients’ insights into diabetes insipidus	146
mTORC1 is the central regulator in pancreatic β-cells	144
Neurons in the diagonal band of Broca moderate food intake	139
Ensuring diverse representation and minimizing conflicts of interest in clinical practice guidelines	133
Reply to ‘Ensuring diverse representation and minimizing conflicts of interest in clinical practice guidelines’	133

Reply to ‘Why the science on T3 and genomics is not settled’	118
Obesity phenotypes: explaining the unexplained	113
The interactions between energy homeostasis and neurovascular plasticity	113
Negative regulator of GDF15 signalling identified	110
A pivotal year for NAFLD and NASH therapeutics	110
Fusion with blood vessel organoids supports pancreatic islet function	109
Steroid hormones as modulators of anti-tumoural immunity	108
Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus	107
The evolving functions of the vasculature in regulating adipose tissue biology in health and obesity	106
Handle with care — interpretation, synthesis and dissemination of data on paracetamol in pregnancy	103
Primary aldosteronism — a multidimensional syndrome	97
New role for bone marrow adipocytes in obesity	93
A role for phosphocreatine in adipose inflammation	92
Genetic risk scores improve prediction of obesity in survivors of childhood cancer	89
Language evolves — so can you	87
New maps and new challenges in the post-genomic era	82
RalA links obesity and mitochondrial dysfunction	79
Urocortin 3 function in glucose metabolism	79
A role for the kidney in metformin action	78
Stem-cell derived pancreatic endoderm cells in the treatment of T1DM	77
Bone and muscle crosstalk in ageing and disease	74
Targeting the incretin system in obesity and type 2 diabetes mellitus	74
Advances in incretin-based therapeutics for obesity	71
GLP1–oestrogen agonist protects β-cells from insulin-deficient diabetes mellitus	70
The metabolic mythos of ketones	68
Inflammation-induced adrenal dysfunction	67
Signals from the dorsal motor nucleus of the vagus promote jejunal fat absorption	66
Luteal phase support in assisted reproductive technology	65
Progress in islet transplantation is more important than ever	62
Advances in basic biology and translation in islet research	62
Endosomal trafficking in metabolic homeostasis and diseases	59
Untangling the pathways of SDHx loss of function	59
Triggering puberty in primates: is it NPY?	59
Author Correction: Drug Insight: selective agonists and antagonists of the glucocorticoid receptor	57
The metabolic benefits of exercise-induced hepatic autophagy	57
REG3G — a potential link between the intestinal microbiome and host physiology	56
Iatrogenic adrenal insufficiency in adults	56
New insights into β-cell failure, regeneration and replacement	54
Tracing the biological roots of obesity resistance in humans	54
Potential downsides of calorie restriction	54
Leptin–thyroid hormone axis affects energy use in muscle	53
The role of ultra-processed food in obesity	53
Islet hormones at the intersection of glucose and amino acid metabolism	52
Skeletal and extraskeletal disorders of biomineralization	50
A global view of hypertensive disorders and diabetes mellitus during pregnancy	50
HIF1α inhibition preserves β-cell function	49
Length of light exposure alters energy metabolism in mice	49
From the perspective of a scientist with Cushing disease, what did not kill me made my science stronger	47
Obesity dysregulates a pituitary–liver axis through disruption of the unfolded protein response	45
GLP1 receptor agonist overcomes SGLT2 inhibitor-related overeating	44

Vitamin D supplementation and fracture risk	44
Investigating the effects of artificial sweeteners	41
Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice	41
Continuous glucose monitoring for the routine care of type 2 diabetes mellitus	41
Remission of T2DM requires early diagnosis and substantial weight reduction	39
Sarcopenic obesity in older adults: a clinical overview	39
Why does the immune system destroy pancreatic β-cells but not α-cells in type 1 diabetes?	38
Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?	38
The complexity of the relationship between thyroid disease and body weight	38
Engineered Tregs prevent diabetes mellitus in mice	37
Lipid droplet biogenesis and functions in health and disease	37
At the 2022 Congress on Obesity	36
The glymphatic system as a nexus between obesity and neurological diseases	35
Large study on hormone therapy for transgender youth provides reassurance amid treatment politicization	34
Targeting senescent cells in ageing-related endocrine diseases	33
Variation in serotonin 2C receptor linked with obesity and behaviour	32
Exercise in adults with type 1 diabetes mellitus	32
Growth hormone-releasing hormone and its analogues in health and disease	32
Metformin and GDF15: where are we now?	32
Sertoli cell lysosomal dysfunction drives age-related testicular degeneration	30
Molecular transducers and the cardiometabolic benefits of exercise	30
Mitigating the environmental effects of healthcare: the role of the endocrinologist	30
Energy intake at the intersection of the clock and ageing	29
Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency	29
Exosomes as novel biomarkers in metabolic disease and obesity-related cancers	29
Epigenetics of type 2 diabetes mellitus and weight change — a tool for precision medicine?	28
New genes associated with adult-onset obesity	28
Highlights from SfE BES 2021	26
Brown adipose tissue fights the battle against leukaemia	26
Individualized and innovative gender healthcare for transgender and nonbinary youth	25
Interventions in people newly diagnosed with type 1 diabetes mellitus	25
Nutrient regulation of bone marrow adipose tissue: skeletal implications of weight loss	25
GWAS gives insights into glucose regulation	25
Advancing precision nutrition: bridging mechanistic insight and clinical implementation	24
Can obesity pharmacotherapy be used to manage male infertility?	24
International consensus guidelines on the implementation and monitoring of vosoritide therapy in individuals with achondroplasia	22
Medically not yet explained symptoms in hypothyroidism	22
A mitochondrial trigger for beige adipocyte development	22
Paracetamol use in pregnancy — caution over causal inference from available data	22
Variation in metformin pharmacokinetics	21
The regulation of endocrine-disrupting chemicals to minimize their impact on health	21
SRC2 controls the refeeding response in mice	21
Diabetes mellitus and work participation	21
Masterful papers that broke open understanding of reproductive neuroendocrinology	20
Metabolic effects of gender-affirming hormone therapy	20
Monogenic diabetes mellitus hidden in autoantibody-negative diabetes mellitus	20
Glial control of neuronal function	19
Combination therapy increases human β-cell mass in vivo	19
Negative effects of ultra-processed foods beyond increasing calories	19
Highlights from ADA 85th Scientific Sessions	19
Author Correction: International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents	18
Sex differences in diabetic kidney disease explained	18
Unravelling the rise in thyroid cancer incidence and addressing overdiagnosis	18
Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemia	18
The complex effects of dietary restriction on longevity and health	18
Environmental factors in declining human fertility	17
Knowledge in youth is wisdom in age: involving young people in research	17
Highlights from ADA 82nd Scientific Sessions	17
Antioxidant liver myeloid cell population identified	17
FGF1 signalling cascade suppresses lipolysis	17
A role for HDAC6 in leptin sensitivity	17
AcroBATics: how dying brown adipocytes trigger browning	17
The study that pioneered islet isolation techniques	16
Obesity induces epigenetic memory in innate immune cells	16
Author Correction: Seeing through the fog: a neuroendocrine explanation for post-COVID cognitive deficits	16
Dysfunctional lipid metabolism in ageing muscle: effects on glucose tolerance	16
An updated view on human neonatal thermogenesis	16
Consensus on acromegaly therapeutic outcomes: an update	15
Bone fragility in type 2 diabetes mellitus: a lot left to explore	15
CAMK1D required for ghrelin-mediated food intake	15
Paracetamol use in pregnancy — neglecting context promotes misinterpretation	15
Genomics suggest role for IGF1 resistance in T2DM	15
Skeletal stem and progenitor cells in bone physiology, ageing and disease	15
IL-17 has a role in whole-body homeostasis	14
New variant for monogenic obesity	14
Antigen-specific Treg cells induce infectious tolerance	13
Targeting hyperglucagonaemia in T2DM	13
The progesterone receptor’s journey through mouse models	13
Thyroid dysfunction in COVID-19	13
Endoscopic sleeve gastroplasty: safe and effective	13

The intersection between ghrelin, metabolism and circadian rhythms	13
Human stomach tissue as alternative source of insulin-producing cells	12
Understanding the complexity of insulin resistance	12
Big data reveals a dominant link between education and diet quality	12
The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits	12
Current and future pharmacotherapies for obesity in children and adolescents	12
Translational perspectives from TSHR, MCT8 and TRα research	11
Liothyronine treatment for hypothyroidism — a patient’s view	11
Stem cells define adipose depot differences	11
Muscle mass loss during GLP1 receptor agonist therapy prevented with GDF8 and activin A blockade	11
Empowering early career researchers: academy-driven pathways to excellence	11
Weight stigma in healthcare settings is detrimental to health and must be eradicated	10
Metabolic and feeding adjustments during pregnancy	10
Pituitary stem cells: past, present and future perspectives	10
Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement	10
The interplay between diabetes mellitus and menopause: clinical implications	10
Osteocalcin influences lifelong adrenal function	10
Modelling human liver disease: from steatotic liver disease to MASH-HCC	9
Adipocyte-derived exosomes drive cancer metastasis	9
Deciphering the role of leptin in weight gain associated with anti-psychotic medications	9
Bile acids in the crosshairs for hypoglycaemia after gastric bypass	8
A transporter on the move	8
Intricacies and obscurities of non-shivering thermogenesis	8
How the WHIMS clinical trial shaped the future of women’s health research	8
JNK at the helm: decoding obesity-driven insulin resistance	8
The role of sweeteners in weight loss	8
Endocrine effects of heat exposure and relevance to climate change	8
Reply to ‘The emerging evidence for non-skeletal health benefits of vitamin D supplementation in adults’	8
Sex differences in skeletal muscle metabolism in exercise and type 2 diabetes mellitus	7
Logic and mechanisms of metabolite signalling	7
Bile acid species shows potential for NAFLD	7
The influence of the circulatory system on tissue ageing: does the fountain of youth lie in our blood?	7
Brain–immune networks: a role for GLP1 receptor	7
Nonenzymatic prevention of insulin hyperresponsiveness by FBP1	7
PCOS — a metabolic condition with health impacts on women and men	7
Glycogen involved in browning of adipocytes	7
Exploring the functions of the myokine feimin	7
Adipose tissue lipolysis controlled by endothelial cells	7
Control loop designs in health and disease	7
Obesity-associated ASB4 controls satiety	7
GLP1-mediated delivery of tesaglitazar improves glucose metabolism in mice	7
Post-operative radioactive iodine administration in patients with low-risk thyroid cancer	6
The relationship between the gut microbiota and thyroid disorders	6
Optimising stem cells for diabetes mellitus therapy	6
Adrenal cysts: an emerging condition	6
Ghrelin’s effects on growth hormone release: to pulse or not to pulse?	6
Exerkines in health, resilience and disease	6
Brain insulin action in women	6
Publisher Correction: Current understanding of the molecular and cellular pathology of diabetic retinopathy	6
A century of glucagon	6
Defining subpopulations of human adipose tissue progenitor cells	6
Cause of rare form of Cushing syndrome found	6
Health equity in endocrinology	5
Emerging mechanisms of obesity-associated immune dysfunction	5
Consensus Statement on the definition and classification of metabolic hyperferritinaemia	5
Cognitive function in T1DM improved by hybrid closed-loop insulin delivery	5
The emerging evidence for non-skeletal health benefits of vitamin D supplementation in adults	5
Oxytocin regulates adipose tissue lipolysis	5
Mammalian models of diabetes mellitus, with a focus on type 2 diabetes mellitus	5
Genomic alterations in thyroid cancer: biological and clinical insights	5
Ketogenic diet in cancer: insufficient stress response?	5
Succinate signalling regulates leptin production in adipocytes	5
HDL metabolism and function in diabetes mellitus	5
Diet composition affects mitochondria trafficking in adipose tissue	5
Early life factors that affect obesity and the need for complex solutions	5
Publisher Correction: Neuro–immuno–endocrinology of the skin: how environment regulates body homeostasis	5
Insulin receptor sets liver clock	5
Highlights from SfE BES 2023	4
Metabolism and exercise: the skeletal muscle clock takes centre stage	4
Approval of teplizumab: implications for patients	4
Metabolically healthy obesity: from epidemiology and mechanisms to clinical implications	4
Polycystic ovary syndrome as a metabolic disease	4
Adipose tissue in communication: within and without	4
Metabolic elasticity — a new trait associated with health?	4
The emerging role of lipidomics in prediction of diseases	4
PTH receptor signalling, osteocytes and bone disease induced by diabetes mellitus	4
Adipose tissue boosts muscle regeneration by supplying mesenchymal stromal cells	4
Graves disease: latest understanding of pathogenesis and treatment options	4
Author Correction: Targeting the incretin system in obesity and type 2 diabetes mellitus	4
Follistatin linked to type 2 diabetes mellitus risk	4
Debunking the myths of intermittent fasting	4
Hyponatraemia in ageing	4
A new model predicts the best medication for patients with type 2 diabetes mellitus	4
Long-term and sequential treatment for osteoporosis	4
Multi-omics analyses of human islets in T1DM	4
Balancing weight and muscle loss in GLP1 receptor agonist therapy	4
Protein misfolding in β-cell failure	3
Sulfonylurea secondary failure mechanism identified	3
The launch of European Hormone Day and EUWIN	3
Diabetes mellitus in breast cancer survivors: metabolic effects of endocrine therapy	3
Progesterone in pregnancy	3
Phase I results for AMG 133	3
A novel anti-obesity peptide that targets the hypothalamus	3
Reply to ‘Slowly progressive insulin dependent diabetes mellitus in type 1 diabetes endotype 2’	3
T-bet+ B cells promote metabolic disease	3